TRDA
Entrada Therapeutics, Inc. · Healthcare
Redmile Group, LLC bought $20.0M of Entrada Therapeutics, Inc.
10% owner
Bought$20,000,000
$20.00Price
1,000,000Shares
+105%Stake
What TRDA did for a copier
- $1,000 copied at Fri, Nov 5 open, $25.33
- $541
- S&P 500, same days
- −2.7%
Measured over 30 trading days, to the Dec 20 close.
Redmile Group, LLC's record
10 other buys with 3 months of prices since 2016: on average −12.3% against the S&P 500, and 3 of 10 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Nov 2. Filed Thu, Nov 4, 9:00 PM ET, after the close. Returns use the Nov 5 open and the Dec 20 close. Not investment advice.